Synapse - Works

Results (2969)

Prognostic implications of mutations in the epidermal growth factor receptor (EGFR) and KRAS among never-smokers with adenocarcinoma of the lung

Meeting Abstract

Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C.; Janjigian, Y. Y.; Riely, G. J.; Kris, M. G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

TWiST analysis to estimate overall benefit for metastatic renal cell carcinoma (mRCC) patients (pts) treated in a phase III trial of sunitinib versus interferon-alfa (IFN-alpha)

Meeting Abstract

Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Celecoxib and aromatase activity in breast cancer: Results from a prospective randomized preoperative trial

Meeting Abstract

Port, E. R.; Subbaramaiah, K.; Brogi, E.; Sampson, M.; Panageas, K.; Dannenberg, A.; Hudis, C.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)

Meeting Abstract

Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

EGFR mutations in men and cigarette smokers with lung adenocarcinoma

Meeting Abstract

Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)

Meeting Abstract

Omuro, A. M.; Beal, K.; Karimi, S.; Chan, T. A.; Panageas, K.; Nayak, L.; Seko, B.; DeAngelis, L. M.; Abrey, L. E.; Gutin, P. H.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

CA125 response to bevacizumab in recurrent ovarian cancer

Meeting Abstract

O'Cearbhaill, R. E.; Zhou, Q.; Iasonos, A.; Diaz, J. P.; Tew, W. P.; Hensley, M. L.; O'Flaherty, C.; Aghajanian, C.; Spriggs, D. R.; Sabbatini, P.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase II study of sunitinib in patients with non-small cell lung cancer (NSCLC) and irradiated brain metastases: Final efficacy and safety results

Meeting Abstract

Novello, S.; Camps, C.; Grossi, F.; Mazieres, J.; Abrey, L. E.; Vernejoux, J.; Thall, A. D.; Usari, T.; Chao, R. C.; Scagliotti, G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Multicenter randomized phase II trial of methotrexate (MTX) and temozolomide (TMZ) versus MTX, procarbazine (PCB), vincristine (VINC), and cytarabine (Ara-C) for primary CNS lymphoma (PCNSL) in elderly patients

Meeting Abstract

Omuro, A. M.; Taillandier, L.; Chinot, O. L.; Ghesquieres, H.; Soussain, C.; Delwail, V.; Choquet, S.; Tanguy, M.; Lamy, T.; Hoang-Xuan, K.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Association of germline polymorphisms in genes involved in the CD44 pathway and clinical outcome in localized gastric adenocarcino (GA)

Meeting Abstract

Ning, Y.; Winder, T.; Power, D. G.; Yang, D.; Zhang, W.; Bohanes, P. O.; Lurje, G.; Tang, L. H.; Shah, M. A.; Lenz, H.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save